Magen BioSciences is a specialty pharmaceutical company currently focused on developing proprietary medical therapies for the dermatology market. Magen's science-driven understanding of skin physiology leads to effective therapies for a number of skin disorders and the prevention of UV radiation related skin damage. The company has assembled an outstanding science, investor and management team. The team includes co-founders of Idexx, Immunex, Alnylam, Momenta, Vertex, Biogen and Genzyme.

Founders: Brian M. Gallagher, Ph.D.